Cayman Chemical is the New World Leader in the manufacturing of generic, bulk prostaglandins for human and veterinary applications. We have the capacity, the inventory, and the regulatory expertise to solve your API sourcing problems—from Alprostadil to Za—well, let’s call it Latanoprost. Please see the comprehensive list on this page, or contact us for further details.
| Prostaglandin E1 | |
| Alprostadil; U-10136; Caverject; Liple; Minprog; Palux; Prostine VR; Prostivas | |
|
Eu. Ph. Purity: 96.0-102.5% Total Impurities: NMT 3.0% USP Purity: 96.0-102.5% Total Impurities: NMT 2.0% |
World (US, CA, AU, NZ, ZA, IN); EU (AT, BE, CZ, DK, EE, FI, FR, DE, GR, IE, IT, LU, NL, PT, SK, ES, SE, GB); Other European Countries (NO, CH) |
| Prostaglandin E2 | |
| Dinoprostone; U-12062; Cerviprost; Minprostin E2; Pepidil; Propess; Prostarmon-E; Prostin E2 | |
|
Eu. Ph. Purity: 97.0-102.0% Total Impurities: NMT 3.0% USP Purity: 97.0-102.0% Total Impurities: NMT 3.0% |
World (US, CA, AU, NZ); EU (AT, BE, DK, FI, FR, DE, GR, IE, IT, LU, NL, PT, ES, SE, GB); Other European Countries (CH) |
| (±)-Cloprostenol (sodium salt) | |
| ICI-80996; Estrumate; Planate | |
|
BP (Veterinary) Purity: 97.5-101.0% Total Impurities: NMT 2.0% |
World (US, AU); EU (AT, BE, DK, EE, FI, FR, DE, GR, IE, IT, LU, NL, PT, ES, SE, GB); Other European Countries (IS, NO, CH) |
| (+)-Cloprostenol (sodium salt) | |
|
BP (Veterinary) Purity: 97.0-101.0% Total Impurities: NMT 2.5% |
EU (AT, CZ, DK, FI, FR, DE, GR, IE, NL, PT, ES) |
| Oestrophan | |
| (±)-Cloprostenol in Ethanol | |
|
Concentration of solution: 9.0-11.0% (w/w) Minimum Purity (+)-cloprostenol: 97.5% |
EU (EE) |
| Superphan | |
| (+)-Cloprostenol in Ethanol | |
|
Concentration of solution: 9.0-11.0% (w/w) Minimum Purity (+)-cloprostenol: 97.5% |
EU (AT, BE, FR, DE, IE, IT, LU, GB) |
| Latanoprost | |
| Xalatan; PhXA-41 | |
|
Purity: 96.0-102.0% Total Impurities: NMT 4.0% |
World (US); EU (EE) |
| Bimatoprost | |
|
Purity: 96.0-102.0% Total Impurities: NMT 4.0% |
- |
*Countries are listed by their ISO country code.
Active Pharmaceutical Ingredient (API) Synthesis under FDA cGMP guidelines:
Cayman can support your early Clinical Phase active compound needs by developing a custom cGMP synthesis to meet your quality, quantity, and timeline requirements.
If you are interested in receiving additional information (including specifications) or pursuing a quote for one of the PG APIs listed above or a custom API project please contact GMP-API@caymanchem.com. Please note that some information may require a confidentiality agreement.
Cayman also regularly quotes on non-GMP custom synthesis.
Cayman is also equipped to provide HPLC analysis of bulk prostaglandin active drug and formulated, aqueous. Our HPLC analytical service uses validated, cGMP-compliant standard operating procedures on IQ/OQ certified instruments. The service has been used for after-market clinical studies, drug manufacturing and quality assurance control.
Please view our Assay Service page for more details.